{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T03:51:09Z","timestamp":1774842669096,"version":"3.50.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,9]],"date-time":"2020-09-09T00:00:00Z","timestamp":1599609600000},"content-version":"vor","delay-in-days":892,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK Medical Research Council (MRC)","doi-asserted-by":"publisher","award":["iCASE studentship"],"award-info":[{"award-number":["iCASE studentship"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK Medical Research Council (MRC)","doi-asserted-by":"publisher","award":["Supplementary fellowship award"],"award-info":[{"award-number":["Supplementary fellowship award"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["10012"],"award-info":[{"award-number":["10012"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["12050"],"award-info":[{"award-number":["12050"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["11052"],"award-info":[{"award-number":["11052"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007903","name":"Bloodwise","doi-asserted-by":"publisher","award":["12036"],"award-info":[{"award-number":["12036"]}],"id":[{"id":"10.13039\/501100007903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK (CRUK)","doi-asserted-by":"publisher","award":["C34999\/A18087"],"award-info":[{"award-number":["C34999\/A18087"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK (CRUK)","doi-asserted-by":"publisher","award":["C24563\/A15581"],"award-info":[{"award-number":["C24563\/A15581"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bournemouth Leukemia Fund","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100000402","name":"Kay Kendall Leukaemia Fund (KKLF)","doi-asserted-by":"publisher","award":["873"],"award-info":[{"award-number":["873"]}],"id":[{"id":"10.13039\/501100000402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mcponline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular & Cellular Proteomics"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1074\/mcp.ra117.000539","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T20:50:18Z","timestamp":1516827018000},"page":"776-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation"],"prefix":"10.1016","volume":"17","author":[{"given":"Harvey E.","family":"Johnston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Larrayoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spiro D.","family":"Garbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Oscier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Strefford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Walewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Cragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1074\/mcp.RA117.000539_bib1","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2141.2005.05550.x","article-title":"Diagnostic criteria for monoclonal B-cell lymphocytosis","volume":"130","author":"Marti","year":"2005","journal-title":"Br. J. Haematol"},{"key":"10.1074\/mcp.RA117.000539_bib3","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1182\/blood-2006-11-056648","article-title":"Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status","volume":"109","author":"Mockridge","year":"2007","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib5","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.194.11.1639","article-title":"Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia","volume":"194","author":"Rosenwald","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.RA117.000539_bib6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"Klein","year":"2001","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.RA117.000539_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA117.000539_bib8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1158\/2159-8290.CD-13-0349","article-title":"Evolution of DNA methylation is linked to genetic aberrations in chronic lymphocytic leukemia","volume":"4","author":"Oakes","year":"2014","journal-title":"Cancer Discov"},{"key":"10.1074\/mcp.RA117.000539_bib9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/leu.2014.252","article-title":"A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact","volume":"29","author":"Queiros","year":"2015","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA117.000539_bib10","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA117.000539_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1182\/blood-2012-09-458265","article-title":"Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia","volume":"121","author":"Rossi","year":"2013","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hon.2028","article-title":"Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone","volume":"31","author":"Marasca","year":"2013","journal-title":"Hematol. Oncol"},{"key":"10.1074\/mcp.RA117.000539_bib13","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib14","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"J. Exp. Med"},{"key":"10.1074\/mcp.RA117.000539_bib15","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"123","author":"Stilgenbauer","year":"2014","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1074\/mcp.RA117.000539_bib17","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2013-02-427641","article-title":"SF3B1 mutations in chronic lymphocytic leukemia","volume":"121","author":"Wan","year":"2013","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib18","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.ccell.2016.10.005","article-title":"Transcriptomic Characterization of SF3B1 Mutation Reveals Its Pleiotropic Effects in Chronic Lymphocytic Leukemia","volume":"30","author":"Wang","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1074\/mcp.RA117.000539_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jprot.2017.01.001","article-title":"From genome to proteome: Looking beyond DNA and RNA in chronic lymphocytic leukemia","volume":"155","author":"Thurgood","year":"2017","journal-title":"J. Proteomics"},{"key":"10.1074\/mcp.RA117.000539_bib20","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/14789450.2017.1275967","article-title":"Functional proteomic insights in B-cell chronic lymphocytic leukemia","volume":"14","author":"Diez","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1074\/mcp.RA117.000539_bib21","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1074\/mcp.M114.044479","article-title":"Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia","volume":"14","author":"Eagle","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA117.000539_bib22","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/pr5002803","article-title":"Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia","volume":"13","author":"Alsagaby","year":"2014","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA117.000539_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2009.07979.x","article-title":"Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia","volume":"148","author":"Rees-Unwin","year":"2010","journal-title":"Br. J. Haematol"},{"key":"10.1074\/mcp.RA117.000539_bib24","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1074\/mcp.M300055-MCP200","article-title":"Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes","volume":"2","author":"Cochran","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA117.000539_bib25","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/pr050028f","article-title":"Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents","volume":"4","author":"Barnidge","year":"2005","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA117.000539_bib26","first-page":"33","article-title":"Protein expression profiling of CLL B cells using replicate off-line strong cation exchange chromatography and LC-MS\/MS","volume":"819","author":"Barnidge","year":"2005","journal-title":"J. Chromatogr"},{"key":"10.1074\/mcp.RA117.000539_bib27","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1182\/blood-2011-02-335125","article-title":"A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia","volume":"118","author":"Perrot","year":"2011","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib28","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.RA117.000539_bib29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nature13302","article-title":"A draft map of the human proteome","volume":"509","author":"Kim","year":"2014","journal-title":"Nature"},{"key":"10.1074\/mcp.RA117.000539_bib30","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1074\/mcp.RA117.000539_bib31","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1074\/mcp.M116.063511","article-title":"Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures","volume":"16","author":"Johnston","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1074\/mcp.RA117.000539_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nmeth.2610","article-title":"DMSO enhances electrospray response, boosting sensitivity of proteomic experiments","volume":"10","author":"Hahne","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1074\/mcp.RA117.000539_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nbt.2839","article-title":"ProteomeXchange provides globally coordinated proteomics data submission and dissemination","volume":"32","author":"Vizcaino","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"10.1074\/mcp.RA117.000539_bib34","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1182\/blood-2012-04-416594","article-title":"The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways","volume":"120","author":"Burkhart","year":"2012","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1182\/blood-2014-08-593061","article-title":"Upregulation of FcgammaRIIb on monocytes is necessary to promote the superagonist activity of TGN1412","volume":"125","author":"Hussain","year":"2015","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib36","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1242\/jcs.00740","article-title":"Endopolyploid cells produced after severe genotoxic damage have the potential to repair DNA double strand breaks","volume":"116","author":"Ivanov","year":"2003","journal-title":"J. Cell Sci"},{"key":"10.1074\/mcp.RA117.000539_bib37","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1182\/blood-2013-06-507335","article-title":"CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism","volume":"122","author":"Zucchetto","year":"2013","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib38","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2009.23.4732","article-title":"Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group","volume":"28","author":"Haferlach","year":"2010","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA117.000539_bib39","doi-asserted-by":"crossref","first-page":"46151","DOI":"10.1074\/jbc.M208946200","article-title":"Molecular cloning of a novel gene encoding a membrane-associated adaptor protein (LAX) in lymphocyte signaling","volume":"277","author":"Zhu","year":"2002","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA117.000539_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ni1072","article-title":"CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity","volume":"5","author":"Chen","year":"2004","journal-title":"Nat. Immunol"},{"key":"10.1074\/mcp.RA117.000539_bib41","doi-asserted-by":"crossref","first-page":"14064","DOI":"10.18632\/oncotarget.7476","article-title":"Carcinoma-associated fucosylated antigens are markers of the epithelial state and can contribute to cell adhesion through CLEC17A (Prolectin)","volume":"7","author":"Breiman","year":"2016","journal-title":"Oncotarget"},{"key":"10.1074\/mcp.RA117.000539_bib42","doi-asserted-by":"crossref","first-page":"810","DOI":"10.15252\/msb.20145880","article-title":"Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation","volume":"11","author":"Satpathy","year":"2015","journal-title":"Mol. Syst. Biol"},{"key":"10.1074\/mcp.RA117.000539_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/bjh.13254","article-title":"The genomic landscape of chronic lymphocytic leukaemia: biological and clinical implications","volume":"169","author":"Strefford","year":"2015","journal-title":"Br. J. Haematol"},{"key":"10.1074\/mcp.RA117.000539_bib44","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","article-title":"Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia","volume":"24","author":"Ferreira","year":"2014","journal-title":"Genome Res"},{"key":"10.1074\/mcp.RA117.000539_bib45","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","article-title":"Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status","volume":"22","author":"Haslinger","year":"2004","journal-title":"J. Clin. Oncol"},{"key":"10.1074\/mcp.RA117.000539_bib46","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","article-title":"Correlation between protein and mRNA abundance in yeast","volume":"19","author":"Gygi","year":"1999","journal-title":"Mol. Cell. Biol"},{"key":"10.1074\/mcp.RA117.000539_bib47","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet"},{"key":"10.1074\/mcp.RA117.000539_bib48","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.3390\/ijms15069407","article-title":"Quantitative proteomics to characterize specific histone H2A proteolysis in chronic lymphocytic leukemia and the myeloid THP-1 cell line","volume":"15","author":"Glibert","year":"2014","journal-title":"Int. J. Mol. Sci"},{"key":"10.1074\/mcp.RA117.000539_bib49","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1021\/pr801102c","article-title":"Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis","volume":"8","author":"Miguet","year":"2009","journal-title":"J. Proteome Res"},{"key":"10.1074\/mcp.RA117.000539_bib50","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2016-01-683128","article-title":"Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration","volume":"128","author":"Pasikowska","year":"2016","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1042\/BST20140272","article-title":"How many lives does CLIMP-63 have?","volume":"43","author":"Sandoz","year":"2015","journal-title":"Biochem. Soc. Trans"},{"key":"10.1074\/mcp.RA117.000539_bib52","doi-asserted-by":"crossref","first-page":"42679","DOI":"10.1074\/jbc.M305695200","article-title":"Functional regulation of tissue plasminogen activator on the surface of vascular smooth muscle cells by the type-II transmembrane protein p63 (CKAP4)","volume":"278","author":"Razzaq","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA117.000539_bib53","doi-asserted-by":"crossref","first-page":"L436","DOI":"10.1152\/ajplung.00415.2005","article-title":"Identification and characterization of p63 (CKAP4\/ERGIC-63\/CLIMP-63), a surfactant protein A binding protein, on type II pneumocytes","volume":"291","author":"Gupta","year":"2006","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol"},{"key":"10.1074\/mcp.RA117.000539_bib54","doi-asserted-by":"crossref","first-page":"37836","DOI":"10.1074\/jbc.M604581200","article-title":"CKAP4\/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients","volume":"281","author":"Conrads","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA117.000539_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1756-9966-29-160","article-title":"Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells","volume":"29","author":"Shahjee","year":"2010","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1074\/mcp.RA117.000539_bib56","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1038\/bcj.2015.82","article-title":"Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia","volume":"5","author":"Palermo","year":"2015","journal-title":"Blood Cancer J"},{"key":"10.1074\/mcp.RA117.000539_bib57","first-page":"5612","article-title":"Negative regulation of lymphocyte activation by the adaptor protein LAX. J","volume":"174","author":"Zhu","year":"2005","journal-title":"Immunol"},{"key":"10.1074\/mcp.RA117.000539_bib58","doi-asserted-by":"crossref","first-page":"18537","DOI":"10.1074\/jbc.M109.012807","article-title":"Prolectin, a glycan-binding receptor on dividing B cells in germinal centers","volume":"284","author":"Graham","year":"2009","journal-title":"J. Biol. Chem"},{"key":"10.1074\/mcp.RA117.000539_bib59","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.3892\/ol.2017.6584","article-title":"WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability","volume":"14","author":"Zhang","year":"2017","journal-title":"Oncol. Lett"},{"key":"10.1074\/mcp.RA117.000539_bib60","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2002-08-2512","article-title":"Free radical stress in chronic lymphocytic leukemia cells and its role in cellular sensitivity to ROS-generating anticancer agents","volume":"101","author":"Zhou","year":"2003","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib61","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.leu.2403388","article-title":"The histone deacetylase inhibitor MS-275 induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia cells","volume":"18","author":"Lucas","year":"2004","journal-title":"Leukemia"},{"key":"10.1074\/mcp.RA117.000539_bib62","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.4161\/epi.22674","article-title":"HDAC isoenzyme expression is deregulated in chronic lymphocytic leukemia B-cells and has a complex prognostic significance","volume":"7","author":"Van Damme","year":"2012","journal-title":"Epigenetics"},{"key":"10.1074\/mcp.RA117.000539_bib63","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1182\/blood-2007-06-098061","article-title":"Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes","volume":"111","author":"Garcia-Manero","year":"2008","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib64","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"key":"10.1074\/mcp.RA117.000539_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2012","journal-title":"Nat. Gen"},{"key":"10.1074\/mcp.RA117.000539_bib66","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/leu.2015.286","article-title":"The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1","volume":"30","author":"Larrayoz","year":"2016","journal-title":"Leukemia"}],"container-title":["Molecular & Cellular Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620332795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535947620332795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/mcp.RA117.000539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:45:58Z","timestamp":1761525958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535947620332795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1535947620332795"],"URL":"https:\/\/doi.org\/10.1074\/mcp.ra117.000539","relation":{},"ISSN":["1535-9476"],"issn-type":[{"value":"1535-9476","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation","name":"articletitle","label":"Article Title"},{"value":"Molecular & Cellular Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1074\/mcp.RA117.000539","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Biochemistry and Molecular Biology, Inc.","name":"copyright","label":"Copyright"}]}}